A total of 930 subjects at high cardiovascular risk ( 420 men and 510 women ) were recruited in the framework of a multicentre , randomized , controlled , parallel-group clinical trial directed at testing the efficacy of the TMD on the primary prevention of cardiovascular disease ( The PREDIMED Study ) .